patient safety

The Delhi High Court has ordered those involved in distributing counterfeit Johnson & Johnson surgical products to pay ₹3.34 crore in damages. Justice Amit Bansal condemned the sale of contaminated medical supplies under J&J’s trademarks, posing serious health risks. The case unraveled an international counterfeit network linked to a Delhi-based firm, M/s Medserve. The court imposed ₹2.34 crore in compensatory damages and ₹1 crore in punitive damages, reinforcing the need to safeguard public health and medical supply chain integrity.